Vele mensen zullen het gevoel wel kennen, ze zitten aan de antibiotica, maar hebben dan een feestje https://antibiotica-kopen.com Antibiotica zijn medicijnen die alleen op recept te krijgen zijn.

Gatewayhealthplan.com

2012 Medicaid StepTherapy
Last Update: 12/12/2011
Brand Name: ACTOplus met
Generic Name: Pioglitazone / Metformin
ActoPlus Met (pioglitazone/metformin) Step Therapy Criteria:
Coverage is provided for a diagnosis of type 2 diabetic mellitus. Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of the following: Brand Name: Actos
Generic Name: Pioglitazone HCl
Actos (pioglitazone) Step Therapy Criteria:

· Coverage is provided for a diagnosis of type 2 diabetic mellitus.
· Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of
o DiaBeta, Glynase, Micronase (glyburide) Brand Name: Avandamet
Generic Name: Rosiglitazone/Metformin HCl
Avandamet (rosiglitazone/metformin) Step Therapy Criteria:

· Coverage is provided for a diagnosis of type 2 diabetic mellitus.
· Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of
o DiaBeta, Glynase, Micronase (glyburide) 2012 Medicaid StepTherapy
Last Update: 12/12/2011
Brand Name: Avandaryl
Generic Name: Rosiglitazone/Glimepiride
Avandaryl (rosiglitazone/glimepiride) Step Therapy Criteria:

· Coverage is provided for a diagnosis of type 2 diabetic mellitus.
· Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of
o DiaBeta, Glynase, Micronase (glyburide) Brand Name: Avandia
Generic Name: Rosiglitazone Maleate
Avandia (rosiglitazone) Step Therapy Criteria:

· Coverage is provided for a diagnosis of type 2 diabetic mellitus.
· Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of
o DiaBeta, Glynase, Micronase (glyburide) Brand Name: Cymbalta
Generic Name: Duloxetine HCl
Cymbalta (duloxetine) Step Therapy Criteria:

· Coverage is provided for a diagnosis of diabetic peripheral neuropathy, fibromyalgia, chronic low back pain, and chronic
· Coverage provided for the treatment of major depressive disorder and generalized anxiety disorder if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of the following generic antidepressants: 2012 Medicaid StepTherapy
Last Update: 12/12/2011
Brand Name: Duetact
Generic Name: Pioglitazone/Glimepiride
Duetact (pioglitazone/glimepiride) Step Therapy Criteria:

· Coverage is provided for a diagnosis of type 2 diabetic mellitus.
· Coverage provided for the treatment if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of
o DiaBeta, Glynase, Micronase (glyburide) Brand Name: Janumet
Generic Name: Sitagliptin phos / metformin
Janumet (sitagliptin/metformin) Step Therapy Criteria

· Coverage is provided for a diagnosis of type 2 diabetes mellitus.
· Coverage is provided for the treatment of type 2 diabetes mellitus if the member has tried and failed a minimum of a 4 week trial or had an intolerance to one of the
o Glucophage (Metformin)o Glucophage XR (Metformin ER)o Glucovance (metformin/glyburide)o Metaglip (metformin/glipizide)o Glumetza (metformin)o Riomet (metformin)o Fortamet (metformin)o Amaryl (glimepiride)o DiaBeta, Glynase, Micronase (glyburide)o Diabinese (chlorpropramide)o Glucotrol, Glucotrol XL (glipizide) o Orinase (tolbutamide)o Tolinase (tolazamide) · When criteria are not met, the request will be forwarded to a Medical Director for review. The physician reviewer must override criteria when, in their professional judgment, the requested medication is medically necessary.
2012 Medicaid StepTherapy
Last Update: 12/12/2011
Brand Name: Januvia
Generic Name: Sitagliptin Phosphate
Januvia (sitagliptin) Step Therapy Criteria
· Coverage is provided for a diagnosis of type 2 diabetes mellitus.
· Coverage is provided for the treatment of type 2 diabetes mellitus if the member has tried and failed a minimum of a 4 week trial or
had an intolerance to one of the following: o DiaBeta, Glynase, Micronase (glyburide) · When criteria are not met, the request will be forwarded to a Medical Director for review. The physician reviewer must override criteria when, in their professional judgment, the requested medication is medically necessary.
Brand Name: Lipitor
Generic Name: Atorvastatin
· Benefit is approved in instances when the patient has tried and failed a generic formulary alternative or in instances when the physician can provide documentation of an intolerance or adverse event to one of the alternatives and an explanation as to why they are trying another medication in the same class. · Benefit is approved for 12 months. · When criteria are not met, the request will be forwarded to a Medical Director for review. The physician reviewer must override criteria when, in their professional judgment, the requested medication is medically necessary.
Brand Name: Restasis
Generic Name: Cyclosporine
Restasis (cyclosporine ophthalmic emulsion) Step Therapy Criteria:

· Benefit is approved to increase tear production, when tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
· Benefit is approved after patient has tried and failed treatment with Tears Naturale, Artificial Tears, Refresh, Genteal, Lacrilube, Celluvisc, or Bion Tears, or has required other treatments such as punctual plugs or goggles.
· Member must be 16 years of age or older · Benefit is approved for 12 months. · When criteria are not met, the request will be forwarded to a Medical Director for review. The physician reviewer must override criteria when, in their professional judgment, the requested medication is medically necessary.

Source: http://www.gatewayhealthplan.com/documents/Medicaid_Step_Therapy.pdf

2005_102 11 _a-771_deutsches Ärzteblatt diabetes-therapie mit kombinationen die zielwerte erreichen - 18.03.2005-

Deutsches Ärzteblatt: Diabetes-Therapie: Mit Kombinat. http://www.aerzteblatt.de/archiv/45974/Diabetes-Ther. VARIA: WIRTSCHAFT - AUS UNTERNEHMEN Diabetes-Therapie: Mit Kombinationen die Zielwerte erreichen Dtsch Arztebl 2005; 102(11): A-771 Unter einer Monotherapie mit oralen Antidiabetika erreicht nur ein Teil derPatienten die angestrebte Stoffwechseloptimierung mit HbA1c-Werten umsiebe

preventivecardiology.com

USING NIACIN AND AVOIDING SIDE EFFECTS The vitamin Niacin (B-3) given in pharmacologic amounts is a very effective medication to combat atherosclerosis and reduce the risk of heart attack and stroke. It has been used for decades but eclipsed in recent years by statin drugs (Lipitor, Zocor, etc.) which are more potent in lowering the LDL so called "bad" cholesterol. However, it i

Copyright © 2012-2014 Medical Theses